Analysis of Advanced Therapeutics Pharmaceutical Outsourcing Market by Oncology and Neurology Indications, 2024 to 2034
Rising Research and Development Activities and Investments across China, the United States, and Germany to Surge Demand for Advanced Therapeutics Pharmaceutical Outsourcing
Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook from 2024 to 2034
The global advanced therapeutics pharmaceutical outsourcing market is expected to surge at a CAGR of 4.4% in the assessment period 2024 to 2034. The market value is projected to increase from US$ 7,592.8 million in 2024 to US$ 11,698.1 million by 2034. The advanced therapeutics pharmaceutical outsourcing market was valued at US$ 7,197.8 million in 2023 and is anticipated to exhibit a y-o-y growth of 4.5% in 2024.
Attributes
Key Insights
Advanced Therapeutics Pharmaceutical Outsourcing Market Size in 2023
US$ 7,197.8 million
Estimated Advanced Therapeutics Pharmaceutical Outsourcing Market Value (2024E)
The increasing complexity of advanced therapeutic modalities, such as gene editing, cell therapy, and mRNA-based drugs, requires specialized knowledge and sophisticated manufacturing capabilities. Pharmaceutical companies are turning to outsourcing partners with advanced technical expertise to navigate the complexities of these novel therapies.
The growing pipeline of advanced therapeutic products, driven by breakthroughs in biotechnology and genomics, has led to a surging demand for outsourcing services. As pharmaceutical companies focus on expanding their portfolios with innovative therapies, outsourcing provides a scalable and cost-effective solution for development and production.
The globalization of clinical trials for advanced therapeutics requires a network of partners with a global presence. Outsourcing facilitates access to diverse patient populations, regulatory environments, and manufacturing capabilities worldwide, supporting efficient and accelerated clinical development.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Historical Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook
The global advanced therapeutics pharmaceutical outsourcing market recorded a historical CAGR of 3.3% from 2019 to 2023.The proliferation of cell and gene therapies represents a transformative shift in healthcare, offering innovative solutions for previously untreatable diseases. The increasing number of companies investing in developing these therapies has created a surge in demand for specialized expertise in manufacturing, quality control, and regulatory compliance.
Cell and gene therapies often involve intricate manufacturing processes, including gene editing, viral vector production, and cell culturing. Outsourcing allows pharmaceutical companies to tap into the specialized capabilities of contract manufacturing organizations (CMOs) with advanced facilities and expertise in these complex processes.
The variability in the production scale for cell and gene therapies, ranging from patient-specific treatments to large-scale manufacturing, necessitates a flexible and scalable approach. Outsourcing allows companies to adjust production volumes based on the specific requirements of their therapies without significant capital investment.
The regulatory landscape for cell and gene therapies is evolving rapidly. Outsourcing partners with a deep understanding of regulatory requirements can guide pharmaceutical companies through the complex approval processes, ensuring compliance and facilitating a smoother path to market.
The increasing adoption of cell and gene therapies is a pivotal driver propelling the growth of the advanced therapeutics pharmaceutical outsourcing market. As pharmaceutical companies prioritize these revolutionary treatment modalities, outsourcing partners equipped with specialized capabilities are becoming indispensable contributors to the successful development and commercialization of advanced therapeutics.
A notable opportunity in the advanced therapeutics pharmaceutical outsourcing market lies in the expanding landscape of mRNA therapies. The increasing focus on mRNA therapies in cancer, infectious diseases, and genetic disorders presents a compelling opportunity for outsourcing partners. As pharmaceutical companies diversify their portfolios, outsourcing providers can offer specialized support in developing and manufacturing mRNA-based treatments.
The versatility of mRNA technology allows for developing a wide range of therapeutic applications. Outsourcing partners can capitalize on this diversity by providing tailored solutions for different mRNA-based treatments, contributing to expanding treatment options available to patients.
mRNA therapies often require specialized expertise in formulation and delivery methods to enhance efficacy and safety. Outsourcing providers focusing on mRNA can offer valuable insights and capabilities in optimizing these critical aspects of therapeutic development.
Find your sweet spots for generating winning opportunities in this market.
Key Advanced Therapeutics Pharmaceutical Outsourcing Market Trends and Analysis
Pharmaceutical firms are looking for outsourcing partners who can offer integrated solutions for the full manufacturing and drug development lifecycle.
Outsourcing partners with a solid grasp of regulatory standards and a track record of attaining compliance are highly sought after, especially in light of the changing regulatory landscape for innovative medicines.
The integration of cutting-edge technology, such as digitalization and automation, is intended to boost productivity and cut expenses in the pharmaceutical development and production processes.
In order to take advantage of cost savings, gain access to a variety of talent pools, and establish a foothold in new markets, pharmaceutical companies have kept looking at outsourcing opportunities on a worldwide scale.
Restrictive Factors for Advanced Therapeutics Pharmaceutical Outsourcing Market
The advanced therapeutics pharmaceutical outsourcing market, while experiencing significant growth opportunities, is also subject to several restrictive factors that pose challenges to its seamless development. When collectively considered, these factors can impact the market dynamics and hinder the full realization of its potential.
The primary restrictive factors is the complex and evolving regulatory landscape governing advanced therapeutics. Regulatory agencies face challenges in establishing clear guidelines as these therapies often involve cutting-edge technologies such as gene editing and cell therapy. This uncertainty can lead to delays in approvals and increase compliance burdens, impacting the speed at which outsourcing services can be leveraged.
The intricate nature of advanced therapeutics, including gene and cell therapies, demands sophisticated scientific expertise and technological capabilities. Finding outsourcing partners with the requisite knowledge in these rapidly advancing fields can be challenging. Technical challenges in scaling up production, maintaining quality, and ensuring consistency also contribute to the complexity.
While outsourcing can offer cost efficiencies, the initial investment in advanced therapeutic technologies and the need for specialized facilities can pose financial challenges. Companies can grapple with the cost of technology transfer, validation, and establishing robust quality control measures with outsourcing partners.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
The global advanced therapeutics pharmaceutical outsourcing market is set to be impacted by the peer or tangential markets in the healthcare division. These include other types of markets, such as the distance health technology industry and topical pain relief industry.
Analysis of these related industries can provide deeper insights that help develop unique differentiating strategies to pursue growth and opportunity in the advanced therapeutics pharmaceutical outsourcing market.
Demand for advanced therapeutics pharmaceutical outsourcing is projected to expand at a 4.4% CAGR during the forecast period. The need for outsourcing partners with expertise in the production, testing, and development of cutting-edge treatment modalities is increasing due to the emphasis on personalized medicine and the advancement of gene and cell therapies.
On the contrary, the distance health technology industry is poised to thrive at a higher CAGR of 16.3% through 2034. Governments and healthcare regulatory organizations are modifying policies to allow and control remote health technologies.
The topical pain relief industry is projected to expand at a CAGR of 5.3% from 2024 to 2034. Customers started paying closer attention to the components in their purchased medical supplies. Transparency in labeling is in vogue, and consumers' desire for natural and organic products devoid of dangerous substances is rising.
The need for outsourcing partners with expertise in the production, testing, and development of these cutting-edge treatment modalities has increased as a result of the emphasis on personalized medicine and the advancement of gene & cell therapies.
Key Trend in Advanced Therapeutics Pharmaceutical Outsourcing Market
Demand for outsourcing services is surging due to the growing interest in and funding for sophisticated medicines, such as gene, cell, and RNA-based therapies.
Distance Health Technology Industry:
Attributes
Distance Health Technology Industry
CAGR (2024 to 2034)
16.3%
Growth Factor
There is an increasing use of wearables and other linked devices for remote patient monitoring. Outside of conventional healthcare settings, these technologies enabled healthcare providers to monitor patients' vital signs and other health indicators.
Key Trend
The demand for remote healthcare services is driving a rapid increase in the deployment of telemedicine systems. Technologies for remote monitoring, virtual visits, and video consultations are becoming more common.
Topical Pain Relief Market:
Attributes
Topical Pain Relief Industry
CAGR (2024 to 2034)
5.3%
Growth Factor
Firms are spending money on research and development to produce sophisticated formulas with improved effectiveness. This involved adding new components to the mix, like menthol, capsaicin, CBD, and other natural extracts, to improve pain relief.
Key Trend
Firms are modifying their marketing and distribution tactics in response to consumers' growing preference for the ease of buying these things online.
Country-wise insights
The table below shows the estimated growth rates of the top five countries. China, Japan, and Spain are set to record high CAGRs of 7.0%, 3.2%, and 2.6%, respectively, through 2034.
Countries
Value CAGR
United States
1.7%
China
7.0%
Japan
3.2%
Germany
1.6%
Spain
2.6%
Growing Demand for Personalized Medicine to Boost Sales in the United States
The United States dominated the global market with a 32.6% market share in 2023. The country is expected to exhibit a CAGR of 1.7% throughout the forecast period. The growing demand for personalized medicine and targeted therapies has fueled the development of advanced therapeutics. Outsourcing partners in the United States are well-positioned to support pharmaceutical companies in meeting the demands of a rapidly expanding market for personalized treatments.
The regulatory environment in the United States has increasingly supported advanced therapeutic products. Regulatory bodies, such as the United States Food and Drug Administration (FDA), have implemented expedited pathways and initiatives to facilitate the development and approval of innovative therapies. This regulatory support provides a conducive ecosystem for outsourcing partners to navigate regulatory requirements efficiently.
Rising Expertise in Advanced Therapeutics to Uplift China’s Market
In 2023, China held a dominant global revenue in East Asia’s market and contributed a share of 7.9% worldwide. The market is expected to grow at a CAGR of 7.0%.
China has witnessed rapid advancements in biotechnology and pharmaceutical research, leading to the development of cutting-edge technologies in gene and cell therapies. The country's commitment to innovation and growing expertise in advanced therapeutics, attract pharmaceutical companies seeking outsourcing partners with specialized capabilities.
China-based outsourcing partners increasingly participate in global clinical trials, allowing sponsors to conduct studies with a more diverse patient population. This globalization trend aligns with the growing emphasis on multi-regional clinical trials, enhancing the attractiveness of China as a destination for outsourcing services.
Growth in Biopharmaceutical Infrastructure to Drive Germany
Germany held 4.4% share in the global market in 2023 and is expected to grow at a CAGR of 1.6% during the forecasted period. Germany has established itself as a leading hub for biopharmaceutical innovation, focusing on advanced therapeutics. The country has a thriving biotechnology sector, research institutions, and a collaborative ecosystem that attracts domestic and international companies seeking outsourcing partners with expertise in cutting-edge therapies.
Germany is investing significantly in biopharmaceutical infrastructure, including state-of-the-art manufacturing facilities and research centers. This infrastructure supports outsourcing partners by providing access to cutting-edge technologies and specialized capabilities required for developing and manufacturing advanced therapeutics.
Rising Demand for Cutting-edge Treatments Driving Demand in Japan
Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) are frequently used by pharmaceutical corporations to outsource different phases of the development process in Japan. Clinical trials, preclinical development, early-stage research, and commercial production are a few examples of these services.
Demand for cutting-edge treatments, such as gene and cell therapies, has increased in Japan. Pharmaceutical companies have been compelled by this demand to look outside for resources and experience to expedite development timeframes and manage the challenges of bringing new medicines to market.
Growing Technological Development Activities in Spain to Gain Traction
In sophisticated therapies, pharmaceutical companies frequently collaborate strategically with outsourcing partners in Spain. These partnerships seek to maximize resources, take advantage of each other's expertise, and hasten the creation and introduction of novel treatments. Technological developments like automation, analytics, and process optimization help manufacturers of advanced treatments operate more profitably and efficiently in Spain.
Category-wise Insights
The below section shows the commercial manufacturing and packaging segment dominated by phases category. It is forecast to thrive at an 4.0% CAGR between 2024 and 2034. Based on therapy, the gene therapy segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 3.8% during the forecast period.
Segment
Value CAGR
Commercial Manufacturing and Packaging (Phases)
4.0%
Gene Therapy (Therapy)
3.8%
Oncology (Indication)
4.0%
Contract Development and Manufacturing Organizations (CDMOs) (Service Type)
3.7%
Demand to Remain High for Contract Development and Manufacturing Organizations
The contract development and manufacturing organizations (CDMOs) held 56.8% market share in 2023. CDMOs offer scalability and flexibility in manufacturing, allowing pharmaceutical companies to adapt production volumes based on the specific requirements of their therapies.
This flexibility is particularly crucial in the dynamic landscape of advanced therapeutics, where production needs may vary widely. CDMOs lead in the advanced therapeutics pharmaceutical outsourcing market due to their specialized expertise, developed infrastructure, flexibility, risk mitigation capabilities, regulatory compliance, cost efficiency, global reach, and collaborative approach to innovation.
Diversity and Scalability of Oncology to Make them Popular
The oncology market share in advanced therapeutics pharmaceutical outsourcing was 46.1% in 2023. The oncology pipeline is rich with innovative therapies, including gene therapies, CAR-T cell therapies, and mRNA-based treatments.
The diverse nature of these therapies necessitates specialized expertise and infrastructure, making outsourcing a strategic choice for pharmaceutical companies looking to bring novel oncology treatments to market. This trend will continue as the oncology landscape evolves with ongoing scientific and technological advancements.
Commercial Manufacturing and Packaging to Gain Momentum through 2034
Commercial manufacturing and packaging have a considerable presence in the advanced therapeutics pharmaceutical outsourcing market, accounting for 54.9% share in 2023. The commercial manufacturing and packaging services lead the market due to their pivotal role in scaling up production, managing supply chains, and contributing to the overall success of bringing advanced therapeutic products from development to commercialization.
Commercial manufacturing and packaging services are essential for scaling up production from clinical to commercial levels. As advanced therapeutic products progress through clinical trials and receive regulatory approval, the demand for large-scale manufacturing increases, making outsourcing partners with scale-up capabilities indispensable.
Competitive Landscape
Collaborations and acquisitions are the growth strategies that leading companies employ to enhance their capabilities, service offerings, and stay competitive in the dynamic landscape of advanced therapeutics.
In August 2022, Catalent Inc. acquired Metrics Contract Services and Contract Development and Manufacturing Organization (CDMO) in North Carolina.
In July 2022, Samsung Biologics Co. planned to double its manufacturing capacity by building four additional plants worth US$ 5.3 billion to solidify its leadership in the CDMO market.
In June 2022, Avid Bioservices launched analytical and process development labs within its viral vector development and CGMP manufacturing facility.
Scope of the Report
Attribute
Details
Estimated Market Size (2024)
US$ 7,592.8 million
Projected Market Size (2034)
US$ 11,698.1 million
Anticipated Growth Rate (2024 to 2034)
4.4%
Forecast Period
2024 to 2034
Historical Data Available for
2019 to 2023
Market Analysis
US$ million for Value
Key Regions Covered
North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, Central Asia, Russia and Belarus, Balkan and Baltic Countries, Middle East and Africa
Key Countries Covered
United States, Canada, Mexico, Brazil, Chile, China, Japan, South Korea, Germany, France, Spain, Italy, BENELUX, Nordic Countries, United Kingdom, BENELUX, Poland, Hungary, Romania, India, Association of Southeast Asian Nations Countries, Australia and New Zealand, GCC Countries, South Africa, Türkiye
Key Market Segments Covered
Service Type, Indication, Therapy, Phases, and Region
Key Companies Profiled
Croda International Plc
Charles River Laboratories International, Inc.
Catalent, Inc.
QuintilesIMS (IQVIA)
Parexel International Corporation
ICON plc
PPD, Inc. (Thermo Fisher Scientific)
LabCorp (Laboratory Corporation of America Holdings)
Advanced Therapeutics Pharmaceutical Outsourcing Industry Segmentation
By Service Type:
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
By Indication:
Oncology
Neurology
Cardiology
Infectious Diseases
Others
By Therapy:
Cell Therapy
Gene Therapy
RNA-based Therapies
Others
By Phases:
Preclinical Services
Clinical Services
Commercial Manufacturing and Packaging
By Region:
North America
Latin America
East Asia
South Asia and Pacific
Western Europe
Eastern Europe
Middle East and Africa
Frequently Asked Questions
How big was the global market in 2023?
The global market was valued at US$ 7,197.8 million in 2023.
What is the global market’s projected value for 2034?
The global market is set to reach a valuation of around US$ 11,698.1 million in 2034.
What was the historical CAGR for the global market?
Demand in the global market increased at a 3.3% CAGR from 2019 to 2023.
What value is the global market estimated to reach by 2024?
The global market is estimated to reach US$ 7,592.8 million by 2024.
What is the United States market outlook?
The United States accounted for around 32.6% share of the global market in 2023.
What is Germany’s market outlook?
Germany held around 4.4% share in the global market in 2023.
What is the outlook for China’s market?
China accounted for a market value share of around 7.9% in 2023 in the global market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Value Added Insights
4.1. Service Type Adoption, By Region
4.2. Overview of CRO and CDMO Services
4.3. Role of Contract Service Providers
4.4. Regulatory Scenario, By Country
4.5. Industry Deals
4.6. PESTEL Analysis by Region
4.7. PORTER Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Research and Development Funding Outlook
5.1.3. Global Life Expectancy Outlook
5.1.4. Global Oncology Spending Outlook
5.1.5. Growing Geriatric Population
5.2. Forecast Factors - Relevance and Impact
5.2.1. Increase in Research and Development Funding and Grants
5.2.2. Increasing Incidence of Genetic Disorders
5.2.3. Service Type Pipeline
5.2.4. Service Type Innovation Trends
5.2.5. Market Consolidation Activities
5.2.6. Prevalence of Chronic Diseases
5.2.7. Shift Towards Technologically Advanced Service Types
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Value (US$ million) Analysis, 2019 to 2023
6.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ million) By Service Type, 2019 to 2023
7.3. Current and Future Market Size (US$ million) Analysis and Forecast By Service Type, 2024 to 2034
7.3.1. Contract Research Organizations (CROs)
7.3.2. Contract Development and Manufacturing Organizations (CDMOs)
7.4. Market Attractiveness Analysis By Service Type
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ million) Analysis By Indication, 2019 to 2023
8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Indication, 2024 to 2034
8.3.1. Oncology
8.3.2. Neurology
8.3.3. Cardiology
8.3.4. Infectious Diseases
8.3.5. Others
8.4. Market Attractiveness Analysis By Indication
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ million) By Therapy, 2019 to 2023
9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Therapy, 2024 to 2034
9.3.1. Cell Therapy
9.3.2. Gene Therapy
9.3.3. RNA-based Therapies
9.3.4. Others
9.4. Market Attractiveness Analysis By Therapy
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ million) By Phases, 2019 to 2023
10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Phases, 2024 to 2034
10.3.1. Preclinical Services
10.3.2. Clinical Services
10.3.3. Commercial Manufacturing and Packaging
10.4. Market Attractiveness Analysis By Phases
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ million) Analysis By Region, 2019 to 2023
11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Region, 2024 to 2034
11.3.1. North America
11.3.2. Latin America
11.3.3. East Asia
11.3.4. South Asia and Pacific
11.3.5. Western Europe
11.3.6. Eastern Europe
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
12.1. Introduction
12.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
12.3.1. By Country
12.3.1.1. United States
12.3.1.2. Canada
12.3.1.3. Mexico
12.3.2. By Service Type
12.3.3. By Indication
12.3.4. By Therapy
12.3.5. By Phases
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Service Type
12.4.3. By Indication
12.4.4. By Therapy
12.4.5. By Phases
12.5. Country Level Analysis and Forecast
12.5.1. United States Market Analysis
12.5.1.1. Introduction
12.5.1.2. Market Analysis and Forecast by Market Taxonomy
12.5.1.2.1. By Service Type
12.5.1.2.2. By Indication
12.5.1.2.3. By Therapy
12.5.1.2.4. By Phases
12.5.2. Canada Market Analysis
12.5.2.1. Introduction
12.5.2.2. Market Analysis and Forecast by Market Taxonomy
12.5.2.2.1. By Service Type
12.5.2.2.2. By Indication
12.5.2.2.3. By Therapy
12.5.2.2.4. By Phases
12.5.3. Mexico Market Analysis
12.5.3.1. Introduction
12.5.3.2. Market Analysis and Forecast by Market Taxonomy
12.5.3.2.1. By Service Type
12.5.3.2.2. By Indication
12.5.3.2.3. By Therapy
12.5.3.2.4. By Phases
13. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Chile
13.3.1.3. Rest of Latin America
13.3.2. By Service Type
13.3.3. By Indication
13.3.4. By Therapy
13.3.5. By Phases
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Service Type
13.4.3. By Indication
13.4.4. By Therapy
13.4.5. By Phases
13.5. Market Trends
13.6. PESTEL Analysis
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
13.9. Country Level Analysis and Forecast
13.9.1. Brazil Market Analysis
13.9.1.1. Introduction
13.9.1.2. Market Analysis and Forecast by Market Taxonomy
13.9.1.2.1. By Service Type
13.9.1.2.2. By Indication
13.9.1.2.3. By Indication
13.9.1.2.4. By Phases
13.9.2. Chile Market Analysis
13.9.2.1. Introduction
13.9.2.2. Market Analysis and Forecast by Market Taxonomy
13.9.2.2.1. By Service Type
13.9.2.2.2. By Indication
13.9.2.2.3. By Indication
13.9.2.2.4. By Phases
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
14.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Service Type
14.3.3. By Indication
14.3.4. By Indication
14.3.5. By Phases
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Service Type
14.4.3. By Indication
14.4.4. By Therapy
14.4.5. By Phases
14.5. Country Level Analysis and Forecast
14.5.1. China Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Service Type
14.5.1.2.2. By Indication
14.5.1.2.3. By Therapy
14.5.1.2.4. By Phases
14.5.2. Japan Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Service Type
14.5.2.2.2. By Indication
14.5.2.2.3. By Therapy
14.5.2.2.4. By Phases
14.5.3. South Korea Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Service Type
14.5.3.2.2. By Indication
14.5.3.2.3. By Therapy
14.5.3.2.4. By Phases
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
15.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Association of Southeast Asian Nations Countries
15.3.1.3. Australia and New Zealand
15.3.1.4. Rest of South Asia and Pacific
15.3.2. By Service Type
15.3.3. By Indication
15.3.4. By Therapy
15.3.5. By Phases
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Service Type
15.4.3. By Indication
15.4.4. By Therapy
15.4.5. By Phases
15.5. Country Level Analysis and Forecast
15.5.1. India Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Service Type
15.5.1.2.2. By Indication
15.5.1.2.3. By Therapy
15.5.1.2.4. By Phases
15.5.2. Association of Southeast Asian Nations Countries Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Service Type
15.5.2.2.2. By Indication
15.5.2.2.3. By Therapy
15.5.2.2.4. By Phases
15.5.3. Australia and New Zealand Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Service Type
15.5.3.2.2. By Indication
15.5.3.2.3. By Therapy
15.5.3.2.4. By Phases
16. Western Europe Market 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
16.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. United States
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Rest of Western Europe
16.3.2. By Service Type
16.3.3. By Indication
16.3.4. By Therapy
16.3.5. By Phases
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Service Type
16.4.3. By Indication
16.4.4. By Therapy
16.4.5. By Phases
16.5. Country Level Analysis and Forecast
16.5.1. Germany Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Service Type
16.5.1.2.2. By Indication
16.5.1.2.3. By Therapy
16.5.1.2.4. By Phases
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Service Type
16.5.2.2.2. By Indication
16.5.2.2.3. By Therapy
16.5.2.2.4. By Phases
16.5.3. Spain Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Service Type
16.5.3.2.2. By Indication
16.5.3.2.3. By Therapy
16.5.3.2.4. By Phases
16.5.4. Italy Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Service Type
16.5.4.2.2. By Indication
16.5.4.2.3. By Therapy
16.5.4.2.4. By Phases
16.5.5. BENELUX Market Analysis
16.5.5.1. Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Service Type
16.5.5.2.2. By Indication
16.5.5.2.3. By Therapy
16.5.5.2.4. By Phases
16.5.6. United Kingdom Market Analysis
16.5.6.1. Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Service Type
16.5.6.2.2. By Indication
16.5.6.2.3. By Therapy
16.5.6.2.4. By Phases
17. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
17.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. Russia
17.3.1.2. Hungary
17.3.1.3. Poland
17.3.1.4. Rest of Eastern Europe
17.3.2. By Service Type
17.3.3. By Indication
17.3.4. By Therapy
17.3.5. By Phases
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Service Type
17.4.3. By Indication
17.4.4. By Therapy
17.4.5. By Indication
17.4.6. By Phases
17.5. Country Level Analysis and Forecast
17.5.1. Russia Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Service Type
17.5.1.2.2. By Indication
17.5.1.2.3. By Therapy
17.5.1.2.4. By Phases
17.5.2. Hungary Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Service Type
17.5.2.2.2. By Indication
17.5.2.2.3. By Therapy
17.5.2.2.4. By Phases
17.5.3. Poland Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Service Type
17.5.3.2.2. By Indication
17.5.3.2.3. By Therapy
17.5.3.2.4. By Phases
18. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Key Players Analyzed
18.3. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
18.4. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
18.4.1. By Country
18.4.1.1. Saudi Arabia
18.4.1.2. Türkiye
18.4.1.3. South Africa
18.4.1.4. North Africa
18.4.1.5. Rest of Middle East and Africa
18.4.2. By Service Type
18.4.3. By Indication
18.4.4. By Therapy
18.4.5. By Phases
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Service Type
18.5.3. By Indication
18.5.4. By Therapy
18.5.5. By Indication
18.5.6. By Phases
18.6. Country Level Analysis and Forecast
18.6.1. Saudi Arabia Market Analysis
18.6.1.1. Introduction
18.6.1.2. Market Analysis and Forecast by Market Taxonomy
18.6.1.2.1. By Service Type
18.6.1.2.2. By Indication
18.6.1.2.3. By Therapy
18.6.1.2.4. By Phases
18.6.2. Türkiye Market Analysis
18.6.2.1. Introduction
18.6.2.2. Market Analysis and Forecast by Market Taxonomy
18.6.2.2.1. By Service Type
18.6.2.2.2. By Indication
18.6.2.2.3. By Therapy
18.6.2.2.4. By Phases
18.6.3. South Africa Market Analysis
18.6.3.1. Introduction
18.6.3.2. Market Analysis and Forecast by Market Taxonomy
18.6.3.2.1. By Service Type
18.6.3.2.2. By Indication
18.6.3.2.3. By Therapy
18.6.3.2.4. By Phases
18.6.4. North Africa Market Analysis
18.6.4.1. Introduction
18.6.4.2. Market Analysis and Forecast by Market Taxonomy
18.6.4.2.1. By Service Type
18.6.4.2.2. By Indication
18.6.4.2.3. By Therapy
18.6.4.2.4. By Phases
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Companies
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Benchmarking
20.2. Competition Dashboard
20.3. Key Development Analysis
20.4. Key Promotional Strategies, By Manufacturers
20.5. Competition Deep Dive
20.5.1. Charles River Laboratories International, Inc.
20.5.1.1. Overview
20.5.1.2. Service Portfolio
20.5.1.3. Sales Footprint
20.5.1.4. Key Financials
20.5.1.5. Key Developments
20.5.1.6. Strategy Overview
20.5.1.7. SWOT Analysis
20.5.2. Catalent, Inc.
20.5.3. QuintilesIMS (IQVIA)
20.5.4. Parexel International Corporation
20.5.5. ICON plc
20.5.6. PPD, Inc. (Thermo Fisher Scientific)
20.5.7. LabCorp (Laboratory Corporation of America Holdings)
20.5.8. Syneos Health
20.5.9. WuXi AppTec
20.5.10. Lonza Group
20.5.11. Piramal Pharma Solutions
20.5.12. SGS SA
20.5.13. Evotec SE
20.5.14. CMC Biologics (Now AGC Biologics)
20.5.15. Marken (A UPS Company)
20.5.16. Cytovance Biologics
20.5.17. Samsung Biologics
20.5.18. CordenPharma
20.5.19. Recipharm AB
20.5.20. Vetter Pharma International GmbH
20.5.21. Cryoport Systems, Inc.
20.5.22. ProPharma Group
20.5.23. Fujifilm Diosynth Biotechnologies
20.5.24. Medpace
20.5.25. Novotech Pty Ltd.
20.5.26. Axcella Health Inc.
20.5.27. Celerion
21. Assumptions and Acronyms Used22. Research Methodology
List of Tables
Table 1: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 2: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 3: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 4: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 5: Global Market Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
Table 6: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 7: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 8: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 9: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 10: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 11: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 12: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 13: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 14: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 15: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 16: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 17: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 18: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 19: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 20: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 21: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 22: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 23: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 25: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 26: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 27: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 28: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 29: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 30: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 31: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 32: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 33: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 34: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 35: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 36: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 37: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 38: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 39: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 40: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 41: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 42: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 43: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 44: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 45: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 46: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 47: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 48: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 49: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 50: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 51: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 52: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 53: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 54: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 55: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 56: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 57: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 58: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 59: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 60: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 61: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 62: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 63: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 64: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 65: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 66: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 67: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 68: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 69: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 70: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 71: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 72: Western Europe Market (Units) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 73: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 74: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 75: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 76: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 77: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 78: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 79: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 80: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 81: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 82: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 83: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 84: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 85: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 86: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 87: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 88: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 89: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 90: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 91: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 92: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 93: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 94: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 95: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 96: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 97: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 98: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 99: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 100: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 101: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 102: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 103: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 104: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 105: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 106: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 107: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 108: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 109: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 110: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 111: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 112: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 113: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 114: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 115: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 116: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 117: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 118: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 119: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 120: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 121: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 122: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 123: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 124: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 125: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 126: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 127: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 128: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 129: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 130: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 131: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 132: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 133: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 134: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 135: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 136: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 137: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Table 138: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
Table 139: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
Table 140: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
Table 141: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
List of Charts
Figure 1: Global Market Value Share By Service Type 2023 (A)
Figure 2: Global Market Value Share By Indication 2023 (A)
Figure 3: Global Market Value Share By Therapy 2023 (A)
Figure 4: Global Market Value Share By Phases 2023 (A)
Figure 5: Global Market Value Share By Country 2023 (A)
Figure 6: Global Market Value Analysis (US$ million), 2019 to 2023
Figure 7: Global Market Value Forecast (US$ million), 2024 to 2034
Figure 8: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 9: Global Market Share Analysis (%), By Service Type, 2024 (E) to 2034 (F)
Figure 10: Global Market Y-o-Y Analysis (%), By Service Type, 2024 to 2034
Figure 11: Global Market Attractiveness Analysis, By Service Type
Figure 12: Global Market Share Analysis (%), By Indication , 2024 (E) to 2034 (F)
Figure 13: Global Market Y-o-Y Analysis (%), By Indication, 2024 to 2034
Figure 14: Global Market Attractiveness Analysis, By Indication
Figure 15: Global Market Share Analysis (%), By Therapy, 2024 (E) to 2034 (F)
Figure 16: Global Market Y-o-Y Analysis (%), By Therapy, 2024 to 2034
Figure 17: Global Market Attractiveness Analysis, By Therapy
Figure 18: Global Market Share Analysis (%), By Phases, 2024 (E) to 2034 (F)
Figure 19: Global Market Y-o-Y Analysis (%), By Phases, 2024 to 2034
Figure 20: Global Market Attractiveness Analysis, By Phases
Figure 21: Global Market Share Analysis (%), By Region, 2024 (E) to 2034 (F)
Figure 22: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 23: Global Market Attractiveness Analysis By Region, 2024 to 2034
Figure 24: North America Market Value Share By Service Type 2023 (A)
Figure 25: North America Market Value Share By Indication 2023 (A)
Figure 26: North America Market Value Share By Therapy 2023 (A)
Figure 27: North America Market Value Share By Phases 2023 (A)
Figure 28: North America Market Value Share By Country 2023 (A)
Figure 29: North America Market Value (US$ million) Analysis, 2019 to 2023
Figure 30: North America Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 31: North America Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 33: North America Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 34: North America Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 36: Latin America Market Value Share By Service Type 2023 (A)
Figure 37: Latin America Market Value Share By Indication 2023 (A)
Figure 38: Latin America Market Value Share By Therapy 2023 (A)
Figure 39: Latin America Market Value Share By Phases 2023 (A)
Figure 40: Latin America Market Value Share By Country 2023 (A)
Figure 41: Latin America Market Value (US$ million) Analysis, 2019 to 2023
Figure 42: Latin America Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 43: Latin America Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 44: Latin America Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 46: Latin America Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 47: Latin America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 48: East Asia Market Value Share By Service Type 2023 (A)
Figure 49: East Asia Market Value Share By Indication 2023 (A)
Figure 50: East Asia Market Value Share By Therapy 2023 (A)
Figure 51: East Asia Market Value Share By Phases 2023 (A)
Figure 52: East Asia Market Value Share By Country 2023 (A)
Figure 53: East Asia Market Value (US$ million) Analysis, 2019 to 2023
Figure 54: East Asia Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 57: East Asia Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 58: East Asia Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 59: East Asia Market Attractiveness Analysis By Country, 2024 to 2034
Figure 60: South Asia and Pacific Market Value Share By Service Type 2023 (A)
Figure 61: South Asia and Pacific Market Value Share By Indication 2023 (A)
Figure 62: South Asia and Pacific Market Value Share By Therapy 2023 (A)
Figure 63: South Asia and Pacific Market Value Share By Phases 2023 (A)
Figure 64: South Asia and Pacific Market Value Share By Country 2023 (A)
Figure 65: South Asia and Pacific Market Value (US$ million) Analysis, 2019 to 2023
Figure 66: South Asia and Pacific Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 67: South Asia and Pacific Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 68: South Asia and Pacific Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 69: South Asia and Pacific Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 70: South Asia and Pacific Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 71: South Asia and Pacific Market Attractiveness Analysis By Country, 2024 to 2034
Figure 72: Western Europe Market Value Share By Service Type 2023 (A)
Figure 73: Western Europe Market Value Share By Indication 2023 (A)
Figure 74: Western Europe Market Value Share By Therapy 2023 (A)
Figure 75: Western Europe Market Value Share By Phases 2023 (A)
Figure 76: Western Europe Market Value Share By Country 2023 (A)
Figure 77: Western Europe Market Value (US$ million) Analysis, 2019 to 2023
Figure 78: Western Europe Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 79: Western Europe Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 80: Western Europe Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 81: Western Europe Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 82: Western Europe Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 83: Western Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 84: Eastern Europe Market Value Share By Service Type 2023 (A)
Figure 85: Eastern Europe Market Value Share By Indication 2023 (A)
Figure 86: Eastern Europe Market Value Share By Therapy 2023 (A)
Figure 87: Eastern Europe Market Value Share By Phases 2023 (A)
Figure 88: Eastern Europe Market Value Share By Country 2023 (A)
Figure 89: Eastern Europe Market Value (US$ million) Analysis, 2019 to 2023
Figure 90: Eastern Europe Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 91: Eastern Europe Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 92: Eastern Europe Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 93: Eastern Europe Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 94: : Eastern Europe Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 95: : Eastern Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 96: : Middle East and Africa Market Value Share By Service Type 2023 (A)
Figure 97: : Middle East and Africa Market Value Share By Indication 2023 (A)
Figure 98: : Middle East and Africa Market Value Share By Therapy 2023 (A)
Figure 99: : Middle East and Africa Market Value Share By Phases 2023 (A)
Figure 100: : Middle East and Africa Market Value Share By Country 2023 (A)
Figure 101: : Middle East and Africa Market Value (US$ million) Analysis, 2019 to 2023
Figure 102: : Middle East and Africa Market Forecast and Y-o-Y growth, 2024 to 2034
Figure 103: : Middle East and Africa Market Attractiveness Analysis By Service Type, 2024 to 2034
Figure 104: : Middle East and Africa Market Attractiveness Analysis By Indication, 2024 to 2034
Figure 105: : Middle East and Africa Market Attractiveness Analysis By Therapy, 2024 to 2034
Figure 106: : Middle East and Africa Market Attractiveness Analysis By Phases, 2024 to 2034
Figure 107: : Middle East and Africa Market Attractiveness Analysis By Country, 2024 to 2034
